BELETSKII et al.
682
Hm, J 7.9 Hz). 13C NMR spectrum (DMSO-d6), δ, ppm:
21.08 (CH3), 114.40 (CH=), 123.30 (Ci), 123.99, 126.96,
129.40, 129.81, 140.11 (CH=), 140.62 (Ci), 141.61 (p-
Tol, Ci), 148.04 (Ci), 168.12 (C3), 174.64 (C5). Mass
spectrum, electron impact, m/z (Irel, %): 307 (100) [M]+,
306 (43), 176 (38) [M–C7H7CN2]+, 133 (95)
[C7H7CNO]+, 102 (24), 91 (14), 77 (33), 51 (10). Found,
%: C 66.20; H 4.37; N 13.50. C17H13N3O3. Calculated,
%: C 66.45; H 4.23; N 13.68. M 307.31.
(80), 103 (38), 89 (16), 77 (31), 63 (11), 51 (15). Found,
%: C 78.58; H 5.17; N 10.25. C18H14N2O. Calculated,
%: C 78.83; H 5.11; N 10.22. M 274.32.
General procedure of addition of N-amino-
phthalimide to styryl-1,2,4-oxadiazoles IIa–IIe. Into
a solution of 1 mmol of oxadiazole IIa–IIe in 30 ml of
dichloromethane cooled to –10°C where was dispersed
0.7 g (5 mmol) of potassium carbonate was added in
turns by small portions within 15 min 162 mg (1 mmol) of
N-aminophthalimide and 443 mg (1 mmol) of lead
tetraacetate. Then the stirring was continued for 10 min,
the mixture was filtered, the precipitate of the inorganic
salt was washed with 20 ml of dichloromethane. The
solvent was distilled off in a vacuum. The reaction product
was recrystallized from a mixture of ethanol with DMF,
5 : 1.
3-Styryl-1,2,4-oxadiazoles IId and IIe. To a solu-
tion of 810 mg (5 mmol) of cinnamoylamidoxime (Id)
and 5 mmol of p-toluoyl or cinnamoyl chloride in 10 ml of
dichloromethane was added dropwise at stirring 0.62 ml
(560 mg, 5.5 mmol) of N-methylmorpholine. The solution
was stirred for 10 min, heated to boiling, washed with
1N HCl (3 × 10 ml). The organic layer was dried with
anhydrous magnesium sulfate, the solvent was distilled
off in a vacuum. To the residue 30 ml of toluene was
added and the solution was heated at reflux for 10 h.
The solvent was distilled off in a vacuum, the residue
was recrystallized from ethanol.
3-(4-Methylphenyl)-5-[rel-(2R,3S)-3-phenyl-1-
phthalimidoaziridin-2-yl]-1,2,4-oxadiazole (IIIa),
invertomers mixture, 88 : 12.Yield 69%. Colorless powder,
1
mp 178–180°C. H NMR spectrum (CDCl3), δ, ppm:
2.35 s, 4.24 d (J 5.1 Hz), 4.86 d (J 5.1 Hz) CH3 group
and aziridine protons of the main invertomer; 2.42 s, 4.43 d
(J 5.8 Hz), 5.37 d (J 5.8 Hz) the same of minor invertomer,
overall 5H; 7.14 d (J 8.0 Hz), 7.28–7.32 m, 7.39–7.47 m,
7.55 d (J 8.0 Hz), 7.54–7.65 m, 8.04 d (J 8.0 Hz) overall
13H, 2Ar + PiN. 13C NMR spectrum of the main
invertomer (CDCl3), δ, ppm: 21.63 (CH3), 42.62 (CHN),
51.62 (CHN), 123.41 (PiN, Cb), 123.46 (p-Tol, Cp),
127.31, 127.68, 128.96, 129.11, 129.56, 130.14 (PiN, Ca),
134.18 (Ph, Ci), 134.33 (PiN, Cc), 141.78 (p-Tol, Ci),
164.83 (NCO), 168.45 (C3), 172.70 (C5). Mass spectrum,
electrospray, m/z (Irel, %): 422.3 (31) [M]+, 276.2 (23)
[M – PiN]+, 221.2 (27), 202.2 (92), 173.1 (56), 159.1
(31), 147.1 (31) [PiNH]+, 132.1 (62), 104.1 (100)
[C6H4CO]+, 76.1 (51). Found, %: C 71.09; H 4.21;
N 13.30. C25H18N4O3. Calculated, %: C 71.08; H 4.29;
N 13.26. M 422.44.
5-(4-Methylphenyl)-3-[(E)-2-phenylethenyl]-
1,2,4-oxadiazole (IId). Yield 55%. Colorless powder,
1
mp 100–101°C. H NMR spectrum (CDCl3), δ, ppm:
2.46 s (3H, CH3), 7.09 d (1H, =CH, J 16.7 Hz), 7.33 m
(5Hapom), 7.61 d (2H, Ph, H°, J 8.7 Hz), 7.81 d (1H, =CH,
J 16.7 Hz), 8.08 d (2H, p-Tol, H°, J 8.7 Hz). 13C NMR
spectrum (CDCl3), δ, ppm: 21.87 (CH3), 113.20 (=CH–
Ht), 121.63 (p-Tol, Cp), 127.58, 128.25, 128.99, 129.50
(Ph, Cp), 129.93, 135.60 (Ph, Ci), 139.16 (=CH–Ph),
143.62 (p-Tol, Ci), 168.49 (C3), 175.28 (C5). Mass
spectrum, electron impact, m/z (Irel, %): 262 (52) [M]+,
261 (100), 128 (28), 119 (58) [C7H7CO]+, 116 (14), 91
(28), 65 (22), 63 (12), 52 (11), 39 (13). Found, %: C 77.93;
H 5.32; N 10.66. C17H14N2O. Calculated, %: C 77.86;
H 5.34; N 10.69. M 262.31.
3-(4-Methylphenyl)-5-[rel-(2R,3S)-3-(4-
methoxyphenyl)-1-phthalimidoaziridin-2-yl]-1,2,4-
oxadiazole (IIIb), invertomers mixture, 82 : 18. Yield
64%. Colorless powder, mp 162–163°C (decomp).
1H NMR spectrum (CDCl3), δ, ppm: 2.34 s, 3.83 s,
4.22 d (J 5.0 Hz), 4.79 d (J 5.0 Hz) CH3, CH3O groups
and aziridine protons of the main invertomer; 2.42 s, 3.74 s,
4.38 d (J 5.9 Hz), 5.30 d (J 5.9 Hz) the same of minor
invertomer, overall 8H; 6.81 d (J 8.4 Hz), 6.96 d
(J 8.4 Hz), 7.13 d (J 8.4 Hz), 7.26–7.32 m, 7.47 d
(J 8.4 Hz), 7.63–7.74 m, 8.02 d (J 8.4 Hz) overall 12H,
2Ar + PiN. 13C NMR spectrum of the main invertomer
(CDCl3), δ, ppm: 21.63 (CH3), 42.49 (CHN), 51.50
3,5-Bis[(E)-2-phenylethenyl]-1,2,4-oxadiazole
(IIe). Yield 56%. Colorless powder, mp 114–115°C.
1H NMR spectrum (CDCl3), δ, ppm: 7.03 d (1H, =CH,
J 16.0 Hz), 7.09 d (1H, =CH, J 16.7 Hz), 7.36–7.44 m
(6H, Hm and Hp), 7.58–7.62 m (4H, H°), 7.75 d (1H,
=CH, J 16.7 Hz), 7.86 d (1H, =CH, J 16.0 Hz). 13C NMR
spectrum (CDCl3), δ, ppm: 110.29 (=CH–Ht), 113.09
(=CH–Ht), 127.59, 128.06 (Ph, Cp), 129.02, 129.21 (Ph,
Cp), 129.57, 130.68, 134.54 (Ph, Ci), 135.54 (Ph, Ci),
139.15 (=CH–Ph), 142.92 (=CH–Ph), 168.33 (C3), 174.66
(C5). Mass spectrum, electron impact, m/z (Irel, %): 274
(58) [M]+, 273 (100), 245 (18), 131 (38), 128 (42), 115
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 46 No. 5 2010